• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • 2026 Election
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • Trump Administration
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • 2026 Election
  • Trump Administration
  • IN FOCUS
  • Commentary
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
  • Newsletters
More
    Home Tags Patent Law

    Tag: Patent Law

    In this photo from Feb. 24, Department of Health and Human Services Secretary Alex Azar speaks in Washington, D.C. So far, Azar and the Trump administration want to leverage greater competition in the pharmaceutical market to entice lower prices. (AP Photo/Jose Luis Magana)
    Healthcare

    Trump’s drug-price crackdown misses the mark, experts say

    Robert King -
    March 13, 2018 5:01 am
    0
    The U.S. Patent and Trademark Office has been known to make mistakes. A 2017 study reported that patent allowance decisions are affected by Washington, D.C., weather. (iStock)
    Economy

    Patent Protection key to US economic progress

    John Thorne -
    February 7, 2018 5:01 am
    0
    In this 2006 photo, Wal-Mart pharmacy technician Mark Pool fills a generic anti-inflammatory prescription at a Little Rock, Ark., Wal-Mart Super Center store. While the Constitution allows for patents, patents are temporary monopolies, meaning that drug companies want to extend their effective life as much as possible - much to the detriment of generics. (AP Photo/Mike Wintroath)
    Healthcare

    Congress can liberate drugs that come off their patents

    Peter Ferrara -
    December 26, 2017 5:01 am
    0
    Industry groups try to deflect blame, while being chided by senators for the rising cost of prescription drugs. (AP Photo/Rich Pedroncelli)
    Healthcare

    Senators want to clamp down on drugmakers’ patent protections

    Robert King -
    December 12, 2017 8:33 pm
    0
    The Tax Cut and Jobs Act eliminates a plethora of breaks and deductions that contribute to the complexity of the tax code. One such gimmick exempts tuition waivers as taxable income -- waivers that disproportionately benefit doctoral students. (iStock)
    Op-Eds

    Rate reductions, not targeted tax favors, key to scientific research

    Ross Marchand -
    November 29, 2017 5:01 am
    0
    The Supreme Court will soon hear a case which centers on whether an administrative body, called the Patent Trial and Appeal Board, may judge patent validity challenges. (iStock)
    Op-Eds

    Supreme Court should affirm patent property rights

    James Edwards -
    November 24, 2017 5:01 am
    0
    While some people are frightened by the prospect of 3D-printed guns -- including, perhaps, some of the judges in the lower courts here -- that is no reason to allow the government to shut down speech about such guns without ensuring that the restrictions comport with the strictures of the First Amendment.
    Healthcare

    Files for 3D printed guns are free speech too

    Washington Examiner Staff -
    September 11, 2017 4:01 am
    0
    Comcast is unwilling to pay TiVo for a license to use this technology, but it is nevertheless continuing to use TiVo's technology in its cable boxes that it imported from abroad. (AP)
    Op-Eds

    The Comcast-TiVo dispute isn’t close enough for instant replay

    Gregory Dolin -
    August 17, 2017 4:01 am
    0
    Caputo is not currently a lobbyist for these patent holders, but says he'll be registering soon. (Twitter/@MichaelRCaputo)
    News

    Former Trump aide Michael Caputo leads patent protest

    Todd Shepherd -
    August 11, 2017 8:17 pm
    0
    A recent Supreme Court ruling has opened the floodgates for trademark applications using obscene language. (AP Photo/Alex Brandon)
    News

    These f**king trademarks might be allowed

    Ryan Lovelace -
    July 30, 2017 4:01 am
    0
    1...567...33Page 6 of 33
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter
    • © Copyright 2026. Washington Examiner. All Rights Reserved.